Fig. 3

Point prevalence of short stature and obesity in the whole cohort. Shown are the point prevalences of a) short stature and b) obesity in the whole cohort at every study visits for the 3 years after enrolment, and after excluding children who received corticosteroids. The vertical lines represent 95%CI